COVID-19: all 7,774 studies
Page 77 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.
- Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization StrategyCompletedNCT04333862
- Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort StudyStatus unknownNCT04333693
- Chloroquine for Mild Symptomatic and Asymptomatic COVID-19TerminatedNCT04333628Phase 2/3
- Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to PositiveStatus unknownNCT04333589Not applicable
- Application of Desferal to Treat COVID-19Status unknownNCT04333550Phase 1/2
- Piclidenoson for Treatment of COVID-19CompletedNCT04333472Phase 2
- Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.TerminatedNCT04333407Not applicable
- Safety in Convalescent Plasma Transfusion to COVID-19TerminatedNCT04333355Phase 1
- Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related PneumoniaStatus unknownNCT04332913
- Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical StudyCompletedNCT04332835Phase 2/3
- Convalescent Plasma for Patients With COVID-19: A Pilot StudyCompletedNCT04332380Phase 2
- Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)Status unknownNCT04332094Phase 2
- COVID-19 Biological Samples CollectionTerminatedNCT04332016
- An Observational Study of Patients With Coronavirus Disease 2019CompletedNCT04331886
- Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 PandemicCompletedNCT04331834Phase 3
- Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 PneumoniaTerminatedNCT04331665Not applicable
- Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDSStatus unknownNCT04331613Phase 1/2
- Chloroquine as Antiviral Treatment in Coronavirus Infection 2020CompletedNCT04331600Phase 4
- Renin-Angiotensin System Inhibitors and COVID-19Status unknownNCT04331574
- COVID-19 Symptom TrackerActive, not recruitingNCT04331509
- Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19Status unknownNCT04331470Phase 2/3
- Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' TriageCompletedNCT04331171
- Survey of the Anxiety Associated With the COVID-19 PandemicStatus unknownNCT04331106
- Protective Role of Inhaled Steroids for Covid-19 InfectionTerminatedNCT04331054Phase 3
- Treatments for COVID-19: Canadian Arm of the SOLIDARITY TrialStatus unknownNCT04330690Phase 3
- A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19CompletedNCT04330586Phase 2
- Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 InfectionWithdrawnNCT04330495Phase 4
- Coronavirus (COVID-19) ACEi/ARB InvestigationSuspendedNCT04330300Phase 4
- Clinical Characteristics and Outcomes of Pediatric COVID-19CompletedNCT04330261
- Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial)WithdrawnNCT04330144Phase 3
- Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 PneumoniaCompletedNCT04329650Phase 2
- ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 DiseaseTerminatedNCT04329611Phase 3
- Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19SuspendedNCT04329572Early Phase 1
- COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational StudyCompletedNCT04329559
- Effects of Using Mobile App on Perceived Stress During COVID-19 PandemicCompletedNCT04329533Not applicable
- Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS)CompletedNCT04329507
- ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 PandemicTerminatedNCT04329195Phase 3
- The Vietnam Chloroquine Treatment on COVID-19CompletedNCT04328493Phase 2
- The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.CompletedNCT04328480Phase 3
- Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG VaccineCompletedNCT04328441Phase 3
- Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare WorkersTerminatedNCT04328285Phase 3
- Effectiveness of Hydroxychloroquine in Covid-19 PatientsStatus unknownNCT04328272Phase 3
- Household Transmission Investigation Study for COVID-19 in Tropical RegionsCompletedNCT04328129Not applicable
- COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19TerminatedNCT04328012Phase 2/3
- Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey StudyCompletedNCT04327531
- Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19TerminatedNCT04327505Phase 2/3
- Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical TrialStatus unknownNCT04327349Not applicable
- BCG Vaccination to Protect Healthcare Workers Against COVID-19CompletedNCT04327206Phase 3
- The GReek Study in the Effects of Colchicine in Covid-19 cOmplications PreventionTerminatedNCT04326790Phase 2
- Early CPAP in COVID-19 Patients With Respiratory Failure.CompletedNCT04326075Not applicable
- Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong KongStatus unknownNCT04325919
- Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19Status unknownNCT04325867Not applicable
- Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in FranceCompletedNCT04325646
- Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 InfectionTerminatedNCT04325633Phase 3
- Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrYStatus unknownNCT04325412
- Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19TerminatedNCT04325061Phase 4
- Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive PatientsCompletedNCT04325048
- A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19Status unknownNCT04324996Phase 1/2
- Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant TherapyStatus unknownNCT04324866
- A Study of a Candidate COVID-19 Vaccine (COV001)CompletedNCT04324606Phase 1/2
- Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane OxygenationCompletedNCT04324528Not applicable
- DAS181 for Severe COVID-19: Compassionate UseCompletedNCT04324489Not applicable
- Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) TrialCompletedNCT04324463Phase 3
- DIgital Online SuPport for COVID-19 StrEssStatus unknownNCT04324190Not applicable
- Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study.CompletedNCT04323878
- COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)CompletedNCT04323839
- Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 RegistryCompletedNCT04323787
- Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)Approved for marketingNCT04323761
- Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg)Status unknownNCT04323644
- Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or DeathWithdrawnNCT04323631Early Phase 1
- Use of Ascorbic Acid in Patients With COVID 19Status unknownNCT04323514Not applicable
- Efficacy of Natural Honey Treatment in Patients With Novel CoronavirusStatus unknownNCT04323345Phase 3
- Traditional Chinese Medicine for Severe COVID-19Status unknownNCT04323332Phase 3
- Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19Status unknownNCT04323228Phase 2/3
- Colchicine Counteracting Inflammation in COVID-19 PneumoniaCompletedNCT04322565Phase 2
- Simple, Safe, Same: Lung Ultrasound for COVID-19CompletedNCT04322487
- Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19.TerminatedNCT04322279
- An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory ComplicationsCompletedNCT04322188
- Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized PatientsActive, not recruitingNCT04321993Phase 2
- Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in HungaryTerminatedNCT04321928Not applicable
- Behavior, Environment And Treatments for Covid-19CompletedNCT04321811
- The Efficacy of Different Anti-viral Drugs in COVID 19 Infected PatientsStatus unknownNCT04321616Phase 2/3
- Hyperimmune Plasma for Critical Patients With COVID-19CompletedNCT04321421Not applicable
- Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)CompletedNCT04321278Phase 3
- Outcomes and Prognostic Factors in COVID-19Status unknownNCT04321265
- The Impact of Camostat Mesilate on COVID-19 InfectionCompletedNCT04321096Phase 1/2
- COVID-19 Pandemic Response NetworkCompletedNCT04320862
- Acute Encephalopathy in Critically Ill Patients With COVID-19Status unknownNCT04320472
- Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.Status unknownNCT04320277Phase 2/3
- Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical StaffStatus unknownNCT04320238Phase 3
- Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19CompletedNCT04320017
- A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory FailureCompletedNCT04319731Early Phase 1
- Social Media Effect on Knowledge Dissemination During COVID-19 Virus OutbreakStatus unknownNCT04319315
- Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant RecipientsCompletedNCT04319172
- Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in PregnancyStatus unknownNCT04319016
- ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19CompletedNCT04318418
- Hypertension in Patients Hospitalized With COVID-19CompletedNCT04318301
- Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)CompletedNCT04318015Phase 3
- Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)Status unknownNCT04317092Phase 2
- Mechanisms for Organ Dysfunction in Covid-19CompletedNCT04316884